EQUITY (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Feb. 16, 2022	Jan. 03, 2022
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Options re-issued to directors			15,900,000
Exercise price			$ 0.05
Option expense		$ 0	$ 821,995
Risk free interest			1.37%
Dividend yield			0.00%
Volatility			142.00%
Market price			$ 0.05
Active directors options					300,000
Recorded options expense			$ 31,807
Options expected life			5 years
Number of Options repriced				900,000
Director [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Options re-issued to directors			900,000
Exercise price			$ 0.08
Option expense			$ 38,444
Risk free interest			1.90%
Dividend yield			0.00%
Volatility			153.00%
Market price			$ 0.08
Options expected life		5 years
Term extension for directors		5 years
Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Officer options granted	15,000,000		15,000,000
Exercise price		$ 0.07	$ 0.07
Years for options		3 years
Option expense		$ 751,744
Risk free interest		1.35%
Dividend yield		0.00%
Volatility		174.00%
Market price		$ 0.07
Option expected life		3 years